193 related articles for article (PubMed ID: 15866553)
1. Sensitized attentional performance and Fos-immunoreactive cholinergic neurons in the basal forebrain of amphetamine-pretreated rats.
Martinez V; Parikh V; Sarter M
Biol Psychiatry; 2005 May; 57(10):1138-46. PubMed ID: 15866553
[TBL] [Abstract][Full Text] [Related]
2. Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats.
Kozak R; Martinez V; Young D; Brown H; Bruno JP; Sarter M
Neuropsychopharmacology; 2007 Oct; 32(10):2074-86. PubMed ID: 17299502
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats.
Nelson CL; Burk JA; Bruno JP; Sarter M
Psychopharmacology (Berl); 2002 May; 161(2):168-79. PubMed ID: 11981597
[TBL] [Abstract][Full Text] [Related]
4. Caffeine elicits c-Fos expression in horizontal diagonal band cholinergic neurons.
Reznikov LR; Pasumarthi RK; Fadel JR
Neuroreport; 2009 Dec; 20(18):1609-12. PubMed ID: 19864960
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of prodynophin, c-fos, and serotonin transporter mRNA following withdrawal from a chronic, escalating dose regimen of D-amphetamine.
Horner KA; Noble ES; Lauterbach EC
Synapse; 2009 Apr; 63(4):257-68. PubMed ID: 19116947
[TBL] [Abstract][Full Text] [Related]
6. No facilitation of amphetamine- or cocaine-induced hyperactivity in adult rats after various 192 IgG-saporin lesions in the basal forebrain.
Jeltsch H; Lazarus C; Cosquer B; Galani R; Cassel JC
Brain Res; 2004 Dec; 1029(2):259-71. PubMed ID: 15542081
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure.
Wunderlich GR; Rotzinger S; Bush DE; DeSousa NJ; Vaccarino FJ
Brain Res; 2004 Mar; 1001(1-2):95-107. PubMed ID: 14972658
[TBL] [Abstract][Full Text] [Related]
8. A sensitizing regimen of amphetamine that disrupts attentional set-shifting does not disrupt working or long-term memory.
Featherstone RE; Rizos Z; Kapur S; Fletcher PJ
Behav Brain Res; 2008 May; 189(1):170-9. PubMed ID: 18299157
[TBL] [Abstract][Full Text] [Related]
9. Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions.
Turner MS; Gray TS; Mickiewicz AL; Napier TC
Brain Struct Funct; 2008 Sep; 213(1-2):197-213. PubMed ID: 18663473
[TBL] [Abstract][Full Text] [Related]
10. Increases in the density of parvalbumin-immunoreactive neurons in anterior cingulate cortex of amphetamine-withdrawn rats: evidence for corticotropin-releasing factor in sustained elevation.
Mohila CA; Onn SP
Cereb Cortex; 2005 Mar; 15(3):262-74. PubMed ID: 15238432
[TBL] [Abstract][Full Text] [Related]
11. Differential c-Fos immunoreactivity in arousal-promoting cell groups following systemic administration of caffeine in rats.
Deurveilher S; Lo H; Murphy JA; Burns J; Semba K
J Comp Neurol; 2006 Oct; 498(5):667-89. PubMed ID: 16917819
[TBL] [Abstract][Full Text] [Related]
12. Attentional demands for demonstrating deficits following intrabasalis infusions of 192 IgG-saporin.
Burk JA; Lowder MW; Altemose KE
Behav Brain Res; 2008 Dec; 195(2):231-8. PubMed ID: 18840475
[TBL] [Abstract][Full Text] [Related]
13. Transient disruption of attentional performance following escalating amphetamine administration in rats.
Kondrad RL; Burk JA
Psychopharmacology (Berl); 2004 Oct; 175(4):436-42. PubMed ID: 15083258
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of stress and amphetamine administration on Fos-like protein expression in corticotropin releasing factor-neurons of the rat brain.
Rotllant D; Nadal R; Armario A
Dev Neurobiol; 2007 May; 67(6):702-14. PubMed ID: 17443818
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of cortical acetylcholine release by orexin A.
Fadel J; Pasumarthi R; Reznikov LR
Neuroscience; 2005; 130(2):541-7. PubMed ID: 15664710
[TBL] [Abstract][Full Text] [Related]
16. Microsphere embolism-induced cortical cholinergic deafferentation and impairments in attentional performance.
Craft TK; Mahoney JH; Devries AC; Sarter M
Eur J Neurosci; 2005 Jun; 21(11):3117-32. PubMed ID: 15978021
[TBL] [Abstract][Full Text] [Related]
17. Repeated amphetamine treatment increases phosphorylation of extracellular signal-regulated kinase, protein kinase B, and cyclase response element-binding protein in the rat striatum.
Shi X; McGinty JF
J Neurochem; 2007 Oct; 103(2):706-13. PubMed ID: 17635666
[TBL] [Abstract][Full Text] [Related]
18. Behavioural consequences of withdrawal from three different administration schedules of amphetamine.
Russig H; Murphy CA; Feldon J
Behav Brain Res; 2005 Nov; 165(1):26-35. PubMed ID: 16157394
[TBL] [Abstract][Full Text] [Related]
19. Effects of single or repeated amphetamine treatment and withdrawal on lung allergic inflammation in rats.
Ligeiro de Oliveira AP; Lazzarini R; Cavriani G; Quinteiro-Filho WM; Tavares de Lima W; Palermo-Neto J
Int Immunopharmacol; 2008 Sep; 8(9):1164-71. PubMed ID: 18602061
[TBL] [Abstract][Full Text] [Related]
20. Reversal of neuronal and cognitive consequences of amphetamine sensitization following chronic treatment with a D1 antagonist.
Selemon LD; Begović A; Williams GV; Castner SA
Pharmacol Biochem Behav; 2010 Sep; 96(3):325-32. PubMed ID: 20600252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
